Stocks
Arena Pharmaceuticals (ARNA) EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -81.0 | -130.2 | 515.9 | -396.4 | -608.4 | -609.5 | ||
| Changes by years, y/y, % | +1 118% | +61% | -496% | -177% | +54% | +146.8% | |||
Arena Pharmaceuticals. EBITDA US GAAP, bln rub
Arena Pharmaceuticals. EBITDA US GAAP, changes, %
Arena Pharmaceuticals. EBITDA US GAAP, sum by quarters, bln rub
Arena Pharmaceuticals (ARNA) EBITDA US GAAP (quarter values) |
||||||||
| 2020Q4 | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | LTM ? | |||
| EBITDA, bln rub | ? | -120.1 | -117.4 | -144.1 | -194.3 | -153.7 | -609.5 | |
| Changes by years, y/y, % | +29% | +13% | +66% | +104% | +28% | |||
| Changes by quarters, q/q, % | +26% | -2% | +23% | +35% | -21% | |||
